133 related articles for article (PubMed ID: 2432126)
1. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
2. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative activities.
Redlich PN; Grossberg SE
Eur J Immunol; 1990 Sep; 20(9):1933-9. PubMed ID: 1698636
[TBL] [Abstract][Full Text] [Related]
4. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
5. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
6. Localization of the receptor binding site of IFN-alpha 2b.
Siemers R; Hensley L; Ozer H
J Immunol; 1988 Sep; 141(5):1550-5. PubMed ID: 2970505
[TBL] [Abstract][Full Text] [Related]
7. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human type I interferon receptor by ligand blotting.
Schwabe M; Princler GL; Faltynek CR
Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
[TBL] [Abstract][Full Text] [Related]
9. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
Kandefer-Szerszeń M; Lundgren E
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I
Immunology; 1991 May; 73(1):8-11. PubMed ID: 1710604
[TBL] [Abstract][Full Text] [Related]
11. Structure-function analysis of human IFN-alpha. Mapping of a conformational epitope by homologue scanning.
Wang L; Hertzog PJ; Galanis M; Overall ML; Waine GJ; Linnane AW
J Immunol; 1994 Jan; 152(2):705-15. PubMed ID: 7506733
[TBL] [Abstract][Full Text] [Related]
12. Epitopes recognized by neutralizing therapy-induced human anti-interferon-alpha antibodies are localized within the N-terminal functional domain of recombinant interferon-alpha 2.
Nolte KU; Günther G; von Wussow P
Eur J Immunol; 1996 Sep; 26(9):2155-9. PubMed ID: 8814261
[TBL] [Abstract][Full Text] [Related]
13. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the antitumor activity of human recombinant interferon alpha-2b in vitro].
Haraguchi S; Koide Y; Matsuo T; Yoshida TO
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3236-43. PubMed ID: 2946265
[TBL] [Abstract][Full Text] [Related]
15. Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analogues.
Taylor-Papadimitriou J; Shearer M; Griffin D
J Immunol; 1987 Nov; 139(10):3375-81. PubMed ID: 2445813
[TBL] [Abstract][Full Text] [Related]
16. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
17. Different functional domains on the transferrin receptor molecule defined by monoclonal antibodies.
Lopez Guerrero JA; Redondo JM; Alarcón B; Sánchez-Madrid F; Rodríguez Moya M; Ortíz de Landazuri M; Bernabeu C; Fresno M
Immunology; 1989 Feb; 66(2):252-7. PubMed ID: 2466771
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
[TBL] [Abstract][Full Text] [Related]
19. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
Gersuk GM; Chang WC; Pattengale PK
J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
